Literature DB >> 12353830

Fatal progressive hepatic necrosis associated with lamotrigine treatment: a case report and literature review.

Kerith Overstreet1, Christopher Costanza, Cynthia Behling, Tarrek Hassanin, Eliezer Masliah.   

Abstract

We present a case of fatal, progressive hepatotoxicity in a patient treated with lamotrigine. After presenting with a rash and fever, she developed elevated liver function tests and clinical sequelae of hepatic failure. The subacute course of her progressive liver damage is documented in serial liver biopsies. While her initial biopsy showed approximately 50% hepatocyte necrosis, her post mortem examination performed three weeks later displayed massive hepatic necrosis with extensive bile duct proliferation. Although she was taking other antipsychotics at the time, her clinical course best parallels other reports of lamotrigine-associated hepatotoxicity. Here we discuss not only the clinicopathologic findings of this case but also review the pertinent literature.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12353830     DOI: 10.1023/a:1019627618972

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  8 in total

Review 1.  Lamotrigine.

Authors:  M J Brodie
Journal:  Lancet       Date:  1992-06-06       Impact factor: 79.321

2.  Multiorgan failure and disseminated intravascular coagulation in severe convulsive seizures.

Authors:  A W Yuen; D J Bihari
Journal:  Lancet       Date:  1992-09-05       Impact factor: 79.321

3.  Acute hepatic failure in a child treated with lamotrigine.

Authors:  R Arnon; D DeVivo; A R Defelice; P G Kazlow
Journal:  Pediatr Neurol       Date:  1998-03       Impact factor: 3.372

4.  Fulminant hepatic failure induced by lamotrigine.

Authors:  A J Makin; S Fitt; R Williams; J S Duncan
Journal:  BMJ       Date:  1995-07-29

5.  Multisystem adverse reaction to lamotrigine.

Authors:  J E Schaub; P J Williamson; E W Barnes; P N Trewby
Journal:  Lancet       Date:  1994-08-13       Impact factor: 79.321

Review 6.  Potential hepatotoxicity of lamotrigine.

Authors:  M Fayad; R Choueiri; M Mikati
Journal:  Pediatr Neurol       Date:  2000-01       Impact factor: 3.372

Review 7.  The tolerability of lamotrigine in children.

Authors:  J A Messenheimer; L Giorgi; M E Risner
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

8.  Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro.

Authors:  N Schaub; A J Bircher
Journal:  Allergy       Date:  2000-02       Impact factor: 13.146

  8 in total
  7 in total

1.  Eosinophilic hepatitis caused by lamotrigine.

Authors:  Oren K Fix; Marion G Peters; Timothy J Davern
Journal:  Clin Gastroenterol Hepatol       Date:  2006-04       Impact factor: 11.382

Review 2.  The safety and tolerability of newer antiepileptic drugs in children and adolescents.

Authors:  Dean P Sarco; Blaise F D Bourgeois
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

3.  Choronic effects of Lamotrigine on liver function in adult male rats.

Authors:  M H Meshkibaf; A Ebrahimi; R Ghodsi; A Ahmadi
Journal:  Indian J Clin Biochem       Date:  2006-03

4.  Lamotrigine-associated reversible severe hepatitis: a case report.

Authors:  Adeline Ngo Su-Yin; Winnie W Tai; Kent R Olson
Journal:  J Med Toxicol       Date:  2008-12

5.  Liver dysfunction induced by systemic hypersensitivity reaction to lamotrigine: case report.

Authors:  Sung Gyu Im; Sun Hong Yoo; Young Min Park; Sang Jin Lee; Sun Kyung Jang; Dong Ok Jeon; Hyo Jin Cho; Mi Jung Oh
Journal:  Clin Mol Hepatol       Date:  2015-06-26

6.  Effect of hydroalcoholic extract of ginger on the liver of epileptic female rats treated with lamotrigine.

Authors:  Ameneh Poorrostami; Farah Farokhi; Reza Heidari
Journal:  Avicenna J Phytomed       Date:  2014-07

7.  Special considerations in the treatment of patients with bipolar disorder and medical co-morbidities.

Authors:  Kimberly D McLaren; Lauren B Marangell
Journal:  Ann Gen Hosp Psychiatry       Date:  2004-04-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.